Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News), today announced the hiring of a senior banker to join its industry-leading healthcare group.

H. Gill Sawhney joined Rodman on August 28 as a Managing Director, bringing 19 years of experience as a banker to the healthcare industry and having closed more than 90 transactions valued at over $8.5 billion over the course of his career. At Rodman, he will focus on life sciences and medical devices as well as other healthcare sectors. Mr. Sawhney was most recently a Managing Director and co-head of healthcare investment banking at Morgan Joseph & Co. Prior to Morgan Joseph, Mr. Sawhney led healthcare investment banking efforts as a Partner and director of life sciences investment banking at Thomas Weisel Partners and before that as Managing Director and head of biotechnology investment banking at ING Barings. He graduated from the University of Pennsylvania in 1988 with a Bachelor of Arts in Economics.

“I'm tremendously pleased to join Rodman's leading healthcare investment banking team,” said Gill Sawhney. “I look forward to bringing Rodman's strengths to bear for my clients, particularly its top-tier equity research capabilities and its leading capital markets effort. I also plan to work with the existing healthcare team to grow our efforts in M&A and advisory assignments as well as traditional equity and equity-linked financings.”

“I am always pleased to announce the hiring of quality professionals to the Rodman platform,” said Michael Lacovara, Rodman’s Chief Executive Officer, “especially so when a new colleague reaffirms our leadership in healthcare. I expect great things from Gill.”

About Rodman & Renshaw Capital Group, Inc.

Rodman & Renshaw Capital Group, Inc. is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC, Rodman Principal Investments, LLC and Miller Mathis & Co., LLC.

Rodman & Renshaw, LLC is a full service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies, along with research and sales and trading services to investor clients that focus on such companies. Rodman is a leading investment banking firm with particular emphasis on “essential” industries with significant capital needs, including health care (especially life science), energy (especially upstream oil and gas), ferrous and non-ferrous metals, shipping, and natural resources, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.

MEMBER FINRA, SIPC

Cautionary Note Regarding Forward Looking Statements

This press release contains forward-looking statements regarding future events and financial performance. In some cases, you can identify these statements by words such as “may,” “might,” “will,” “should,” “except,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue,” the negative of these terms and other comparable terminology. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Company’s control. There are or may be important factors that could cause our actual results to materially differ from our historical results or from any future results expressed or implied by such forward looking statements.

These factors include, but are not limited to, those discussed under the section entitled “Risk Factors” in our Annual Report on Form 10-K, filed March 14, 2008, which is available at the Securities and Exchange Commission website at www.sec.gov. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. The Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason.